(Q28365753)

11

object named as

O P Kallioniemi

0 references

author name string

J Torhorst

1

0 references

C Bucher

2

0 references

J Kononen

3

0 references

P Haas

4

0 references

M Zuber

5

0 references

O R Köchli

6

0 references

F Mross

7

0 references

H Dieterich

8

0 references

H Moch

9

0 references

M Mihatsch

10

0 references

G Sauter

The American Journal of Pathology

12

0 references

language of work or name

English

0 references

publication date

December 2001

0 references

published in

0 references

volume

159

0 references

issue

6

0 references

page(s)

2249-56

0 references

cites work

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Tissue microarrays for high-throughput molecular profiling of tumor specimens

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Lack of prognostic value of p53 protein expression in node-negative breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

p53 protein expression in human breast carcinoma: lack of prognostic potential for recurrence of the disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Heterogeneity in hormone receptor status in primary and metastatic breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Influence of tissue heterogeneity on the determination of steroid receptors in breast cancer

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

HER-2/neu oncogene protein and prognosis in breast cancer

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Tissue microarrays for gene amplification surveys in many different tumor types.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850582

Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors

27 November 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963075-1

Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963075-1

Expression profiling using cDNA microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963075-1

Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963075-1

Heterogeneity of intratumour proliferative activity in primary breast cancer: biological and clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963075-1

Human breast cancer: Heterogeneity of estrogen binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963075-1

Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963075-1

Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963075-1

Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11733374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/S0002-9440(10)63075-1

1 reference

release_cohc7hnq3zei3azxt72flpk5wa

Fatcat ID

0 references

1 reference

1 reference

PubMed publication ID

11733374

1 reference